Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2

Persistent infection with the high-risk subset of genitotropic human papillomavirus (HPV) genotypes is a necessary cause of cervical cancer. Given the global burden of cervical cancer, a low-cost, broadly protective vaccine is needed. RG-1 is a cross-neutralizing and protective monoclonal antibody t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Alphs, Hannah H., Gambhira, Ratish, Karanam, Balasubramanyam, Roberts, Jeffrey N., Jagu, Subhashini, Schiller, John T., Zeng, Weiguang, Jackson, David C., Roden, Richard B. S.
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2008
Assuntos:
Biological Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2299222/
https://ncbi.nlm.nih.gov/pubmed/18413606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0800868105
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados